Spiro Rombotis
2023
In 2023, Spiro Rombotis earned a total compensation of $661K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 13% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,581 |
|---|---|
| Salary | $560,131 |
| Other | $52,337 |
| Total | $661,049 |
Rombotis received $560.1K in salary, accounting for 85% of the total pay in 2023.
Rombotis also received $48.6K in option awards and $52.3K in other compensation.
Rankings
In 2023, Spiro Rombotis' compensation ranked 1,663rd out of 2,878 executives tracked by ExecPay. In other words, Rombotis earned more than 42.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,663 out of 2,878 | 42nd |
Division Manufacturing | 972 out of 1,582 | 39th |
Major group Chemicals And Allied Products | 618 out of 891 | 31st |
Industry group Drugs | 602 out of 854 | 30th |
Industry Pharmaceutical Preparations | 429 out of 614 | 30th |
Source: SEC filing on May 7, 2024.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2023.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020